About InforMed
We were in those group chats.
That is the whole reason this exists. InforMed was founded by two pharmacists who watched clinical decisions get made on the back of advice from people whose credentials nobody had ever checked.
Convenient, fast, and completely unaccountable.
In a world of instant messaging, the line between convenience and clinical accuracy has blurred. Group chats offer speed, but they have no verification, no peer-reviewed sourcing, and no GDPR position of the kind professional practice demands.
Healthcare professionals need a space that bridges modern connectivity and old-fashioned clinical rigour. From WhatsApp groups that quietly breach information governance to public forums where registration can't be confirmed, the channels clinicians rely on were never designed for clinical advice. So we built one that was.
Every part of InforMed, from verification through to data handling, is built to meet the standards UK healthcare professionals are already expected to uphold.
The Team
Clinical founders, backed by an established technology partner.
Founders
Why we built it: we watched clinical decisions get made on the back of advice from people whose credentials nobody had ever checked. The channels clinicians rely on were never designed for clinical advice, so we built a community that was.
GPhC-registered pharmacist with experience in community pharmacy and NHS outpatient pharmacies at the Royal London Hospital, UCLH, Guy's and St Thomas' and King's College Hospital. Has also worked in the private sector as interim lead dispensary pharmacist, and is currently employed in the pharmaceutical industry.
GPhC-registered pharmacist who has worked across community and hospital sectors, including some of London's leading NHS trusts: The Royal Marsden, Guy's and St Thomas', St Bartholomew's and Imperial. Currently works in the pharmaceutical sector as a medical affairs professional.
Technology partner: AIME
Our CTO, DevOps, CIO and IT Compliance functions are currently filled by our software development partner, AIME. Their management team is supported by 50+ engineers.

Has founded, scaled and sold businesses in marketing, systems integration and SaaS, for clients including Legal & General, Santander, HSBC, AXA, Pfizer and AstraZeneca.

20+ years scaling technology and product platforms. Has delivered work for BT, Virgin, Vodafone, Pfizer, Deutsche Bank, JP Morgan, Credit Suisse, Channel 4 and O2.

15+ years' leadership across technology, SaaS and digital businesses, leading growth, product and operational transformation across international markets and regulated sectors.
What we found
How big the problem actually is.
Independent research by the founders. The real figure is expected to be higher. These are only the groups we could see.
The image shows only the WhatsApp and Telegram groups we currently know of, from our independent research.
What this means for you
If you're a member of the public
The doctor, pharmacist or nurse treating you may have sourced advice about your care from someone with no registration, no verification and no accountability, believing them to be a regulated colleague.
If you're a healthcare professional
Most of the clinical advice groups you rely on today have no gating, no identity verification, and no audit trail of what was said or by whom.
Team disclosures
Mazafar Fiaz
I am currently employed by a pharmaceutical company and this project was initiated prior to my employment there. This project is being developed outside of my contracted hours and there is no company involvement in the project at all. All posts regarding this project are my own views and are not to be seen as the company's official position.
Tahir Manan
I am currently employed by Norgine and this project was initiated prior to my employment there. This project is being developed outside of my contracted hours and there is no company involvement in the project at all. All posts regarding this project are my own views and are not to be seen as the company's official position.
Build it with us.
The beta is open, and early members shape what comes next.





